Buys
Open market- Shares
- Avg price
- Total value
Isaac Barchas - Director at Immunome Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- IMNM on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Isaac Barchas in Immunome Inc.
Sells
Open market- Shares
- -383,200
- Avg price
- $21.74
- Total value
- -$8,330,080
Net
Past year- Shares
- -383,200
- Share %
- -100%
- Total value
- -$8,330,080
Reported holdings for Isaac Barchas in Immunome Inc.
Form 4 holding
Director
Immunome Inc.
- Security class
- Common Stock
- Shares / value
- 2,031,181
- Estimated value
- $45,376,583
- Report date
- 22 Dec 2025
- Price
- $22.34
- Ownership
- Indirect
Form 4 holding
Director
Immunome Inc.
- Security class
- Common Stock
- Shares / value
- 92,211
- Estimated value
- $1,420,971
- Report date
- 22 Dec 2025
- Price
- $15.41
- Ownership
- Direct
Form 4 holding
Director
Immunome Inc.
- Security class
- Director Stock Option (right to buy)
- Shares / value
- 18,864
- Estimated value
- Report date
- 10 Jun 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Isaac Barchas in Immunome Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.